Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 3, 1997, Pages 735-738

  Russo, Diego ^a   Tumino, Salvatore ^b   Arturi, Franco ^g   Vigneri, Paolo ^b,f   Grasso, Giuseppe ^c   Pontecorvi, Alfredo ^d   Filetti, Sebastiano ^e   Belfiore, Antonino ^b  

^a UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c Ospedale S Pietro e Gravina   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e Dipto di Med Sperim e Clinica   (Italy)

^f NATIONAL CANCER INSTITUTE   (Italy)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; CYTOSINE; RADIOACTIVE IODINE; THYROTROPIN RECEPTOR;

ADULT; ARTICLE; CASE REPORT; CERVICAL LYMPH NODE; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; LUNG METASTASIS; LYMPH NODE METASTASIS; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; THYROID CARCINOMA; THYROID NODULE; THYROIDECTOMY; THYROTOXICOSIS;

BASE SEQUENCE; CARCINOMA; FEMALE; GENES; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MIDDLE AGED; POINT MUTATION; POLYMERASE CHAIN REACTION; RECEPTORS, THYROTROPIN; THYROID NEOPLASMS; THYROTOXICOSIS;

EID: 0031059155     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.3.735     Document Type: Article

References (27)

1. Pinsky SM. 1986 Current status of thyroid imaging. In: Freeman LM, ed. Current concepts in diagnostic nuclear medicine, vol 3, no. 1. Chicago: MacMillan Professional Journals; 4-12.
2. Belfiore A, La Rosa GL, Giuffrida D, et al. 1995 The management of thyroid nodules. J Endocrinol Invest. 18:155-158.
3. Fabbro D, Di Loreto C, Beltrami CA, Belfiore A, Di Lauro R, Damante G. 1994 Expression of thyroid specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasm. Cancer Res. 54:4744-4749.
4. Rubenfeld S, Wheeler TM. 1988 Thyroid cancer presenting as a hot thyroid nodule: report of a case and review of the literature. Thyroidology. 1:63-68.
5. Russo D, Arturi F, Filetti S. 1996 Thyroid-stimulating hormone receptor gene mutations and polymorphism in thyroid diseases. Curr Opin Endocrinol Diabetes. 3:428-432.
6. Russo D, Arturi F, Wicker R, et al. 1995 Genetic alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab. 80:1347-1351.
7. Nagayama Y, Kaufman KD, Seto P, Rapoport B. 1989 Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. Biochem Biophys Res Commun. 165:1184-1190.
8. Sanger F, Nicklen S, Coulson AR. 1977 DNA sequencing with chain terminating inhibition. Proc Natl Acad Sci USA. 82:488-492.
9. Filetti S, Belfiore A, Amir S, et al. 1988 Thyrotoxicosis due to thyroid cancer: role of thyroid stimulating antibodies. N Engl J Med. 318:753-759.
10. Gross JL, Vasques Moraes I. 1996 Thyroid hormone-producing metastases in differentiated thyroid cancer. J Endocrinol Invest. 19:21-24.
11. 3-Hyprthyreose beim metastasierenden follikularen Schilddrusenkarzinom. Nuklearmedizin. 25:201-204.
12. Kosugi S, Shenker A, Mori T. 1994 Constitutive activation of cyclic AMP but not phosphatidylinositol signaling caused by four mutations in the 6th transmembrane helix of the human thyrotropin receptor. FEBS Lett. 356:291-294.
13. Lyons J, Landis CA, Harsh G, et al. 1990 Two G protein oncogenes in human endocrine tumors. Science. 249:655-659.
14. O' Sullivan C, Barton CM, Staddon SL, Brown CL, Lemoine NR. 1991 Activating point mutations of the gsp oncogene in human thyroid adenomas. Mol Carcinogen. 4:345-349.
15. Said S, Schlumberger M, Suarez HG. 1994 Oncogenes and anti-nncogenes in human epithelial thyroid tumors. J Endocrinol Invest. 17:371-379.
16. Parma J, Duprez L, Van Sande J, et al. 1993 Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 365:649-651.
17. Porcellini A, Ciullo I, Laviola L, Amabile G, Fenzi G, Avvedimento VE. 1994 Novel mutations of thyrotropin receptor in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy. J Clin Endocrinol Metab. 79:657-661.
18. Paschke R, Tonacchera M, Van Sande J, Parma J, Vassart G. 1994 Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid. J Clin Endocrinol Metab. 79:1785-1789.
19. Russo D, Arturi F, Suarez HG, et al. 1996 Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab. 81:1548-1551.
20. Van Sande J, Parma J, Tonacchera M, Swillens S, Dumont J, Vassart G. 1995 Somatic and germline mutations of the TSH receptor gene in thyroid diseases. J Clin Endocrinol Metab. 80:2577-2585.
21. Sα protein-adenylate cyclase pathway may not be sufficient to generate toxic adenomas. J Clin Endocrinol Metab. 81:1898-1904.
22. Suarez HG, du Villard JA, Caillou B, Schlumberger M, Parmentier C, Monier R. 1991 gsp mutations in human thyroid tumours. Oncogene. 6:677-679.
23. Russo D, Arturi F, Schlumberger M, et al. 1995 Activating mutations of the TSH receptor in differentiated thyroid carcinomas. Oncogene. 11:1907-1911.
24. Carcangiu ML, Zampi G, Rosai J. 1984 Poorly differentiated ("insular") thyroid carcinoma. Am J Surg Pathol. 8:655-667.
25. Flynn SD, Forman BH, Stewart AF, Kinder BK. 1986 Poorly differentiated ("insular") carcinoma of the thyroid gland: an aggressive subset of differentiated thyroid neoplasms. Surgery. 104:963-970.
26. Papotti M, Botto Mica F, Favero A, Palestini N, Bussolati G. 1993 Poorly differentiated thyroid carcinomas with primordial cell component. Am J Surg Pathol. 17:291-301.
27. Belfiore A, Garofalo MR, Giuffrida D, et al. 1990 Increased aggressiveness of thyroid cancer in patients with Graves' disease. J Clin Endocrinol Metab. 70:830-835.